DELVENDYS

Serial Number 99084507
686

Registration Progress

Application Filed
Mar 14, 2025
Under Examination
Approved for Publication
May 13, 2025
Published for Opposition
May 13, 2025
Registered

Basic Information

Serial Number
99084507
Filing Date
March 14, 2025
Published for Opposition
May 13, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
May 13, 2025
Application
Pending
Classes
005

Rights Holder

Eli Lilly and Company

03
Address
Lilly Corporate Center
Indianapolis, IN 46285

Ownership History

Eli Lilly and Company

Original Applicant
03
Indianapolis, IN

Eli Lilly and Company

Owner at Publication
03
Indianapolis, IN

Legal Representation

Attorney
Bruce W. Longbottom

Application History

8 events
Date Code Type Description
May 13, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 13, 2025 PUBO A PUBLISHED FOR OPPOSITION
May 7, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 14, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 10, 2025 DOCK D ASSIGNED TO EXAMINER
Mar 14, 2025 MAFR O APPLICATION FILING RECEIPT MAILED
Mar 14, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 14, 2025 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer’s disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, obstructive sleep apnea, osteoarthritis, pain, Parkinson’s disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Classification

International Classes
005